AU2024904188A0 - Lipid formulations for treatment of the eye - Google Patents

Lipid formulations for treatment of the eye

Info

Publication number
AU2024904188A0
AU2024904188A0 AU2024904188A AU2024904188A AU2024904188A0 AU 2024904188 A0 AU2024904188 A0 AU 2024904188A0 AU 2024904188 A AU2024904188 A AU 2024904188A AU 2024904188 A AU2024904188 A AU 2024904188A AU 2024904188 A0 AU2024904188 A0 AU 2024904188A0
Authority
AU
Australia
Prior art keywords
eye
treatment
lipid formulations
lipid
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024904188A
Inventor
Furqan MAULVI
Mark Willcox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NewSouth Innovations Pty Ltd
Original Assignee
NewSouth Innovations Pty Ltd
Filing date
Publication date
Application filed by NewSouth Innovations Pty Ltd filed Critical NewSouth Innovations Pty Ltd
Publication of AU2024904188A0 publication Critical patent/AU2024904188A0/en
Pending legal-status Critical Current

Links

AU2024904188A 2024-12-18 Lipid formulations for treatment of the eye Pending AU2024904188A0 (en)

Publications (1)

Publication Number Publication Date
AU2024904188A0 true AU2024904188A0 (en) 2025-01-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP4100406A4 (en) Compositions for treatment of ocular diseases
AU2021381495A9 (en) Formulations and methods for treating conditions of the eye
AU2024904188A0 (en) Lipid formulations for treatment of the eye
EP4232458A4 (en) Compounds and methods for the treatment of ocular disorders
AU2024904192A0 (en) (O-acyl)-hydroxy fatty acid formulations for treatment of the eye
EP4069220A4 (en) Ophthalmic formulations for the treatment of presbyopia
HK40100081A (en) Lipid formulations of triazoloquinazolinone compounds
HK40110065A (en) Ionic-liquid-based formulations for the prevention or treatment of neurological diseases
AU2025903067A0 (en) Lipid Nanoparticle Formulations
HK40126024A (en) Compositions for the treatment of cftr-mediated diseases
HK40118482A (en) Stable formulations comprising thiotepa
HK40108349A (en) Compositions of growth factor for the treatment of eye disease
HK40091727A (en) Formulations for personalized methods of treatment
HK40092769A (en) Compositions and methods for the treatment of ocular diseases
HK40085518A (en) Compositions for treatment of ocular diseases
HK40092791A (en) Compositions and methods for the treatment of eye diseases
HK40094127A (en) Compounds and formulations for treating ophthalmic diseases
AU2024261036A1 (en) Device for the treatment of ocular disorders
HK40113464A (en) Compositions and methods for eye diseases
AU2024900796A0 (en) Formulations
HK40112689A (en) Formulations of radiprodil
HK40114134A (en) Ocular surgical magnet apparatus
AU2025901970A0 (en) Implants for the prolonged release of active agents
AU2024903392A0 (en) Agents for treatment of optic conditions
HK40117787A (en) Stable formulations of shr0302